BioCentury
ARTICLE | Company News

Icos licenses Afferon's RTX

November 5, 2001 8:00 AM UTC

ICOS exclusively licensed from Afferon (Wayne, Penn.) worldwide rights to RTX resiniferatoxin to treat urological disorders. ICOS will pay an upfront license fee, milestones and royalties. In addition, ICOS develop and commercialize RTX and its analogs. ...